A mucoadhesive patch loaded with freeze-dried liposomes for the local treatment of oral tumors

Drug Deliv Transl Res. 2023 May;13(5):1228-1245. doi: 10.1007/s13346-022-01224-4. Epub 2022 Sep 1.

Abstract

Oral cancers affect millions of people globally, with increasing incidences among adults aged 35 and above. Poor drug uptake by lesions in the oral cavity following systemic administration, as well as limited localized treatment modalities for oral tumors, result in poor patient quality of life and high mortality. Here, we describe a solid, dissolvable, bioadhesive alginate patch containing freeze-dried doxorubicin-loaded liposomes as a local treatment for oral tumors located on the tongue. By varying the alginate-to-liposome ratio in the mucoadhesive patch, we could control the degree of bioadhesion to the tongue and the release profile of the drug-loaded liposomes from the matrix. In vitro, exposing squamous cell carcinoma (SCC) to the alginate mucoadhesive patch or tablet resulted in dose-dependent cancer-cell death. In vivo, the efficacy of the local treatment was demonstrated in mice bearing orthotopic SCC tumors in the tongue. The bioadhesive patch, applied directly above the lesion, significantly reduced the tumor size and treatment-associated side effects compared to implanted patches or systemic drug administration. This study demonstrates that local bioadhesive therapies are effective in treating cancers of the oral cavity.

Keywords: Alginate; Freeze-dried; Liposome; Mucoadhesive; Nanoparticle; Oral cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alginates
  • Animals
  • Carcinoma, Squamous Cell* / drug therapy
  • Liposomes
  • Mice
  • Mouth Neoplasms* / drug therapy
  • Quality of Life

Substances

  • Liposomes
  • liposomal doxorubicin
  • Alginates